RY 176.57 0.438% SHOP 158.97 0.9526% TD 79.31 0.1515% ENB 61.27 0.1471% BN 84.87 -1.1646% TRI 235.65 1.718% CNQ 46.46 -3.4898% CP 106.585 0.2021% CNR 153.9 0.1627% BMO 134.58 0.3654% BNS 77.82 0.9339% CSU 4727.8198 1.6729% CM 89.33 0.0336% MFC 45.32 0.421% ATD 82.32 -0.8551% NGT 58.47 -0.0513% TRP 68.21 -0.3943% SU 53.98 -1.5861% WCN 268.6 -0.3229% L 186.66 0.1771%
Company Overview: Defiance Silver Corp. (TSXV: DEF) is quite active in the mining sector in Mexico, focusing on both precious and base metals. Their Zacatecas projects are situated in a well-known mining region with a rich history of silver production, which could potentially offer significant opportunities. Karyopharm Therapeutics Inc. (NASDAQ: KPTI) is indeed a notable player in the pharmaceutical industry. As a commercial-stage company, Karyopharm focuses on innovative therapies targeting nuclear export pathways, a key mechanism involved in various diseases, particularly cancer. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
On September 05, 2024, the S&P 500 index settled at 5503.41 with a week till date loss of 0.46%; moreover, the tech-heavy NASDAQ composite declined by ~3.31% on a WTD basis and settled at 17127.66. While, the Russell 2000 settled at 2132.05, reflecting a loss of ~3.86% on WTD basis.
Considering the Canadian market, the benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week on a negative note and continued the momentum. On September 05, 2024, the index closed at 550.28 with an overall week-to-date (WTD) loss of 3.10%. Real estate, industrials, energy, and consumer cyclicals were the leading sectors, while financials, technology, healthcare, basic materials, and consumer non-cyclicals were the laggards on Thursday.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.